🟢 Pacific Biosciences is trading 6% up today with no identified catalyst

Pacific Biosciences is trading 6.03% higher at $1.50, with no confirmed catalyst identified.

• No September 24, 2026 earnings, regulatory, partnership, financing, analyst, or other material company-specific catalyst was identified.
• PacBio’s latest listed announcement was its September 3 Morgan Stanley healthcare conference participation, which does not explain the move.
• The rise comes despite a weaker broader market and biotech sector; it may reflect trading-specific demand rather than a confirmed fundamental catalyst.